Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Theracrine, a US developer of cancer therapeutics, has named Steven Kelly as President and CEO.
Subscribe to our email newsletter
Most recently, Kelly worked as the chief commercial officer for BioVex, and was responsible for leading the company’s commercial efforts.
Prior to BioVex, Kelly was the founder and CEO of Innovive Pharmaceuticals, an oncology company with four products under development.
Kelly said they will continue to expand their team and advance their lead compounds into the clinic.